GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Science... ( ATLANTA Jan. 17 /- GeoVax Labs In...)

GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry

Date:1/17/2008

ATLANTA, Jan. 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing HIV-1/AIDS vaccines, announced it has been named a "2008 Deal of the Year" award winner by Georgia Bio. Georgia Bio recognized GeoVax for receiving a $15 million IPCAVD (Integrated Preclinical/Clinical AIDS VACCINE Development grant) from the National Institutes of Health (NIH) in October 2007. The award will be presented at Georgia Bio's annual awards dinner on January 24, 2008.

The Integrated IPCAVD Program supports product development and optimization in the later stages of vaccine research and includes human studies. The $15 million IPCAVD grant will strongly support GeoVax's promising HIV/AIDS vaccine development program. This grant is believed to be one of the largest grants of its kind to be awarded in the last fiscal year.

GeoVax will utilize this substantial source of funding for HIV/AIDS vaccine development activities and human clinical trials. The IPCAVD grant also supports expansion of GeoVax's scientific and management team, its GLP testing program, as well as its process development activities.

GeoVax employees Laurie Donald, Michael Hellerstein and Mark Reynolds will receive the award on behalf of the company. GeoVax Vice President Harriet Robinson and President Don Hildebrand will not be present as they will be attending a Phase 2 clinical (human) trial planning meeting for their AIDS vaccine with the HVTN (HIV Vaccine Trials Network [Division of National Institutes of Health) in Seattle.

"GeoVax embodies the spirit of Georgia Bio's 'Deal of the Year' Award, which recognizes companies that support our organization's goal of making the state synonymous with innovative life sciences research and products," said Charles Craig, Georgia Bio's President. "The awarding of the NIH grant underscores the potential that GeoVax's vaccines have to both prevent and treat HIV/AIDS."

GeoV
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
9. Immtech Reports Fiscal Second Quarter 2008 Results
10. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
11. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)

Post Your Comments:

(Date:12/2/2009)...FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today... stage of a two-stage pivotal Phase II study evalu...,s 2009 H1N1 virus-like particle (VLP) pandemic in... in collaboration with Avimex Laboratories of Mexi...o and potentially other countries. ,, In Stage ...

(Date:12/2/2009)...stCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq:...ug Administration (FDA) has granted Fast Track des...novel, potentially first-in-class, oral anti-cance...e (PI3K)/Akt pathway, for the treatment of relapse...ack program of the FDA is designed to facilitate t...

(Date:12/2/2009)...e/ -- Adults are more likely to lose their visio... over, the odds of losing vision are one in three,...cer are one in six and odds of a woman developing ...ens the overall health of aging adults by increasi...to complete daily tasks. ,, Vision loss in adul...

[0] NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico [0] Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma [0] Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer

..., Feb. 25 Associated Foot & Ankle Specialists,tod...lcers due to diabetes,to participate in the MATRIX...of a new product, Excellarate, for the potential t...t ulcers. Excellarate is an,investigational produc...ng., The MATRIX trial is a randomized, double-bli...

...EY HILLS, Mass., Feb. 25 Joseph F. Finn, Jr.,CPA,...vBiotics, as a result,of growing interest from pro...ategy for further advancement of the company,s pro...erial drug candidates in,combination antibiotic th...mpounds, though most of the interest for combinati...

Other Medicine Technology:ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 2

Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics

(Date:12/2/2009)...atches now available, many more to come, NIH direc...Day News) -- Thirteen stem cell lines have been a...yer-funded research, and many more such lines will...ounced Wednesday. , These are the first additio...h funded by the U.S. National Institutes of Health...

(Date:12/2/2009)... SAN FRANCISCO, Dec. 2 ...bies are born contaminated with a plastics chemica...ess must act immediately to protect infants and mo...bills to ban bisphenol A, or BPA, in food and beve...in of California and Rep. Edward Markey of Massach...

(Date:12/2/2009)..., MONTREAL, Dec. 2 /PRNewswire/ - As part of its c...world, Wyeth, now a part of Pfizer, has pledged mo...ctor concentrates to the World Federation of Hemop...e to the WFH,s Humanitarian Aid Program, and will ...ls. ,, "This donation will directly support bui...

(Date:12/2/2009)... , Ruling by federal government ends nine ... ANGELES, Dec. 2 More t...iser Permanente facilities across Southern Califor... National Union of Healthcare Workers (NUHW). ,...n NUHW in February, but SEIU delayed the election ...

(Date:12/2/2009)... MAJoseph Balboni loves sports. An avid tennis pla...ar-old insurance agent became increasingly frustra...conus, a degenerative eye disorder. Unable to retu...es, he faced the prospect of a corneal transplant ...ree years ago, Balboni discovered an alternative t...

Breaking Medicine News(10 mins):Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2 Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3 Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2 Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2 Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2 Health News:Brandeis studies evaluate visionary approach to improving eyesight 2

[0] U.S. Approves New Stem Cell Lines for Publicly Funded Research [0] Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA [0] The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH [0] Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers [1] Brandeis studies evaluate visionary approach to improving eyesight

...t our troops" is no longer just,a slogan -- it,s a...ND.org and a,new marketing campaign for the renam... pro bono support of JWT Atlanta., By focusing on...jured troops and their families and to ensure,that...

..., at the annual,research conference of the America... leading scientists discussed the state of the evi...cancer risk., Dietary supplements are a $22 billi...can be either protective or,harmful., The opening...

...Strategy for Invisicare Is Put In Place, LAS VEGA...SKVI), the developers of Invisicare, a patented po...ied products, today announced,the appointment of G...al markets. Dr. Cauwenbergh has vast,international...

... Last year, Mimi Avery of Texas learned her three...of a golf ball. A half-year earlier in Iowa, Peggy...d with the same rare form of cancer, called medull...t muscle tumor. , CHICAG...

...ogy, Inc. ("US Oncology" or,"the Company"), one of...es,reported revenue of $821.7 million, EBITDA of $...t income of $3.9 million and operating cash flow,o...ion, EBITDA of $(217.7) million, Adjusted EBITDA o...

...rimary Endpoints Achieved for SCOLR,s 12 Hour,Ibup...,(Amex: DDD ) today reported favorable top-line r...e the safety and efficacy of its 12 hour CDT(R),60...et both co-primary endpoints (p<0.0001), and h...

Bob Woodruff Foundation and JWT Introduce Marketing Campaign and Unveil www.ReMIND.org Scientists Debate Dietary Supplements and Cancer Risk at AICR Conference Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board Three Women in Health Crises Go Online to Form Lifelong Friendships : Mothers of Boys with Cancer Find Support, Encouragement and Each Other at CarePages.com US Oncology Reports Third Quarter 2008 Results SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen

...AirSeps AirLife On-board Oxygen Concentrators were...plemental oxygen passengers and are still in use t...ernments FAA/STC approval for this product to be i...irSep set the standard years ago for travel oxygen...

...r is the most compact, lightweight concentrator av...is unit was designed to accommodate the traveling,...,Operating as a pulse flow device, and combining t... an oxygen conserver in one unit, LifeStyle gives ...

...elivery costs associated with 5 LPM-and-above oxyg...ost of providing oxygen at higher liter flow and h...market. Fewer parts, combined with greater reliabi...s and unnecessary inventory. The Millennium M10 is...

Oxygen Conserving Cannula

Medicine Products:

AirLife On-board Oxygen Concentrator LifeStyle Portable Oxygen Concentrator Millennium M10 Concentrator Oxygen Conserving Cannula

GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Science...( ATLANTA Jan. 17 /- GeoVax Labs In...),Health